PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat digestive tumors
Disease control OngoingThis study is testing whether the drug abemaciclib can help control advanced digestive system neuroendocrine tumors that have spread and stopped responding to standard treatments. The drug works by blocking enzymes that tumor cells need to grow. About 20 patients with these speci…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill targets rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing an experimental oral drug called CVM-1118 for people with advanced neuroendocrine tumors that have stopped responding to standard treatments. The main goal is to see if the drug can slow or stop the cancer from growing. Researchers will also closely monitor …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
New test could better predict pancreatic tumor danger
Knowledge-focused OngoingThis study aims to see if checking for the loss of two specific proteins (ATRX and DAXX) in small biopsy samples taken before surgery can help doctors better predict how aggressive a pancreatic neuroendocrine tumor will be. Researchers will follow 100 patients with these non-func…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC